Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

Compare

22.98

+0.13 (0.57%)

At close: Dec 24, 2025, 1:00 PM EST

22.99

+0.01 (0.04%)

After-hours: Dec 24, 2025, 4:36 PM EST

Legend Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Operating Revenue	908.71	620.98	284.96	116.68	65.4	75	Upgrade
Other Revenue	0.34	6.26	0.18	0.33	3.42	-	Upgrade
Revenue	909.05	627.24	285.14	117.01	68.83	75	Upgrade
Revenue Growth (YoY)	74.76%	119.97%	143.70%	70.00%	-8.23%	21.36%	Upgrade
Cost of Revenue	776.37	648.13	526.43	401.01	313.35	232.16	Upgrade
Gross Profit	132.68	-20.88	-241.29	-284.01	-244.52	-157.16	Upgrade
Selling, General & Admin	323.53	284.26	200.93	174.05	149.5	72.71	Upgrade
Operating Expenses	323.53	284.26	200.93	174.05	149.5	72.71	Upgrade
Operating Income	-190.86	-305.15	-442.22	-458.05	-394.02	-229.87	Upgrade
Interest Expense	-19.92	-21.62	-21.79	-10.8	-0.9	-0.2	Upgrade
Interest & Investment Income	45.8	61.2	54.49	8.18	0.97	2.93	Upgrade
Currency Exchange Gain (Loss)	-55.78	108.51	-28.65	-9.88	-	0.07	Upgrade
Other Non Operating Income (Expenses)	3.65	3.34	-82.61	24.22	-12.27	-1.23	Upgrade
EBT Excluding Unusual Items	-217.1	-153.71	-520.78	-446.33	-406.22	-228.29	Upgrade
Gain (Loss) on Sale of Investments	-	-	0.66	0.6	-	0.05	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-0.97	-0.06	Upgrade
Asset Writedown	-5.39	-4.42	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	-	-79.98	Upgrade
Pretax Income	-222.49	-158.13	-520.12	-445.72	-407.2	-308.29	Upgrade
Income Tax Expense	17.21	18.89	-1.86	0.63	-3.61	-41.91	Upgrade
Net Income	-239.7	-177.03	-518.25	-446.35	-403.58	-266.37	Upgrade
Net Income to Common	-239.7	-177.03	-518.25	-446.35	-403.58	-266.37	Upgrade
Shares Outstanding (Basic)	184	183	176	159	141	118	Upgrade
Shares Outstanding (Diluted)	184	183	176	159	141	118	Upgrade
Shares Change (YoY)	0.86%	3.84%	10.71%	12.91%	19.21%	18.15%	Upgrade
EPS (Basic)	-1.30	-0.97	-2.94	-2.81	-2.87	-2.25	Upgrade
EPS (Diluted)	-1.30	-0.97	-2.94	-2.81	-2.87	-2.26	Upgrade
Free Cash Flow	-188.68	-158.14	-413.36	-222.21	-240.66	-249.26	Upgrade
Free Cash Flow Per Share	-1.02	-0.86	-2.35	-1.40	-1.71	-2.11	Upgrade
Gross Margin	14.59%	-3.33%	-84.62%	-242.73%	-	-209.55%	Upgrade
Operating Margin	-21.00%	-48.65%	-155.09%	-391.48%	-572.49%	-306.49%	Upgrade
Profit Margin	-26.37%	-28.22%	-181.75%	-381.48%	-586.38%	-355.16%	Upgrade
Free Cash Flow Margin	-20.76%	-25.21%	-144.97%	-189.91%	-349.67%	-332.34%	Upgrade
EBITDA	-181.24	-294.29	-431.48	-445.41	-385.88	-223.63	Upgrade
EBITDA Margin	-19.94%	-46.92%	-151.32%	-	-	-298.18%	Upgrade
D&A For EBITDA	9.62	10.86	10.73	12.65	8.14	6.23	Upgrade
EBIT	-190.86	-305.15	-442.22	-458.05	-394.02	-229.87	Upgrade
EBIT Margin	-21.00%	-48.65%	-155.09%	-	-	-	Upgrade
Revenue as Reported	909.05	627.24	285.14	117.01	68.83	75	Upgrade

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q